Alivus Life Sciences Limited (NSE:ALIVUS)
915.00
+5.00 (0.55%)
Mar 6, 2026, 3:29 PM IST
-10.65% (1Y)
| Market Cap | 112.31B |
| Revenue (ttm) | 25.12B |
| Net Income (ttm) | 5.44B |
| Shares Out | 122.74M |
| EPS (ttm) | 44.23 |
| PE Ratio | 20.69 |
| Forward PE | 18.88 |
| Dividend | 5.00 (0.55%) |
| Ex-Dividend Date | Sep 1, 2025 |
| Volume | 62,657 |
| Average Volume | 59,458 |
| Open | 909.90 |
| Previous Close | 910.00 |
| Day's Range | 897.60 - 919.95 |
| 52-Week Range | 819.00 - 1,225.10 |
| Beta | 0.07 |
| RSI | 51.52 |
| Earnings Date | May 15, 2026 |